美沙酮和丁丙诺啡使用和滥用的指标：我们了解多少？
Indicators of buprenorphine and methadone use and abuse: what do we know?
机构信息
Addiction Research Institute, The University of Texas at Austin, Austin, Texas 78703, USA.
出版信息
Am J Addict. 2010 Jan-Feb;19(1):73-88. doi: 10.1111/j.1521-0391.2009.00008.x.
Abstract
Abuse of prescription opioids is a growing problem. The number of methadone pain pills distributed now exceeds liquid methadone used in opioid treatment, and the increases in buprenorphine indicators provide evidence of the need to monitor and intervene to decrease the abuse of this drug. The need for additional and improved data to track trends is discussed, along with findings as to the characteristics of the users and combinations of drugs. Data on toxicities related to methadone or buprenorphine, particularly in combination with other prescribed drugs, are presented and clinical implications and considerations are offered. These findings underscore the need for physicians to be aware of potential toxicities and to educate their patients regarding these issues.
摘要
处方类阿片类药物滥用是一个日益严重的问题。现在发放的美沙酮止痛药片数量超过了阿片类药物治疗中使用的液体美沙酮，丁丙诺啡指标的增加表明有必要进行监测和干预，以减少这种药物的滥用。文中讨论了对额外和改进数据的需求，以跟踪趋势，并提供了有关使用者特征和药物组合的发现。本文还介绍了与美沙酮或丁丙诺啡相关的毒性数据，特别是与其他处方药物联合使用时的毒性数据，并提出了临床意义和考虑因素。这些发现强调了医生需要意识到潜在的毒性，并就这些问题对患者进行教育。
相似文献
1
Indicators of buprenorphine and methadone use and abuse: what do we know?
Am J Addict. 2010 Jan-Feb;19(1):73-88. doi: 10.1111/j.1521-0391.2009.00008.x.
2
Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.
Am J Addict. 2010 Jan-Feb;19(1):4-16. doi: 10.1111/j.1521-0391.2009.00005.x.
3
Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
Drug Alcohol Rev. 2014 Sep;33(5):491-8. doi: 10.1111/dar.12143. Epub 2014 Apr 16.
4
Methadone and buprenorphine toxicity in children.
Am J Addict. 2010 Jan-Feb;19(1):89-95. doi: 10.1111/j.1521-0391.2009.00002.x.
5
Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Int J Drug Policy. 2016 Mar;29:57-65. doi: 10.1016/j.drugpo.2015.12.024. Epub 2015 Dec 31.
6
Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Eur Addict Res. 2019;25(1):10-19. doi: 10.1159/000496112. Epub 2019 Jan 9.
7
[Interactions with methadone and buprenorphine].
Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2364-6. doi: 10.4045/tidsskr.09.0471.
8
Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
Harm Reduct J. 2013 Oct 18;10:27. doi: 10.1186/1477-7517-10-27.
9
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
10
Less driving impairment on buprenorphine than methadone in drug-dependent patients?
J Neuropsychiatry Clin Neurosci. 2001 Fall;13(4):527-8. doi: 10.1176/jnp.13.4.527.
引用本文的文献
1
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.
Mol Psychiatry. 2024 Mar;29(3):624-632. doi: 10.1038/s41380-023-02353-z. Epub 2023 Dec 25.
2
Ketogenic diet enhances the effects of oxycodone in mice.
Sci Rep. 2023 May 9;13(1):7507. doi: 10.1038/s41598-023-33458-8.
3
Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic.
JAMA Netw Open. 2022 Jul 1;5(7):e2223708. doi: 10.1001/jamanetworkopen.2022.23708.
4
Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
Am J Drug Alcohol Abuse. 2020 May 3;46(3):266-272. doi: 10.1080/00952990.2020.1719410. Epub 2020 Feb 24.
5
Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research.
Neuropsychopharmacology. 2019 Jan;44(2):259-273. doi: 10.1038/s41386-018-0232-4. Epub 2018 Oct 3.
6
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.
Infect Dis Clin North Am. 2018 Jun;32(2):347-370. doi: 10.1016/j.idc.2018.02.001.
7
Management of opioid use disorders: a national clinical practice guideline.
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
8
Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount.
Drug Alcohol Depend. 2017 Oct 1;179:362-369. doi: 10.1016/j.drugalcdep.2017.06.033. Epub 2017 Jul 26.
9
Low-dose naloxone provides an abuse-deterrent effect to buprenorphine.
J Pain Res. 2015 Nov 4;8:791-8. doi: 10.2147/JPR.S90780. eCollection 2015.
10
Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers.
Clin Pharmacokinet. 2015 Aug;54(8):837-49. doi: 10.1007/s40262-015-0238-6.
本文引用的文献
1
Benzodiazepines, methadone and buprenorphine: interactions and clinical management.
Am J Addict. 2010 Jan-Feb;19(1):59-72. doi: 10.1111/j.1521-0391.2009.00007.x.
2
Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006.
NCHS Data Brief. 2009 Sep(22):1-8.
3
Patterns of abuse among unintentional pharmaceutical overdose fatalities.
JAMA. 2008 Dec 10;300(22):2613-20. doi: 10.1001/jama.2008.802.
4
Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
Drug Alcohol Depend. 2009 Jan 1;99(1-3):338-44. doi: 10.1016/j.drugalcdep.2008.07.017. Epub 2008 Sep 27.
5
Opioid pharmacology.
Pain Physician. 2008 Mar;11(2 Suppl):S133-53.
6
Methadone- and heroin-related deaths in Florida.
Am J Drug Alcohol Abuse. 2008;34(3):347-53. doi: 10.1080/00952990802010892.
7
An in vitro approach to potential methadone metabolic-inhibition interactions.
Eur J Clin Pharmacol. 2007 Sep;63(9):821-7. doi: 10.1007/s00228-007-0327-z. Epub 2007 Jun 28.
8
Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.
J Clin Psychopharmacol. 2007 Jun;27(3):273-8. doi: 10.1097/JCP.0b013e3180592ad2.
9
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Addiction. 2007 Apr;102(4):616-22. doi: 10.1111/j.1360-0443.2006.01731.x. Epub 2007 Feb 6.
10
Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.
Curr Pharm Des. 2007;13(2):241-50. doi: 10.2174/138161207779313704.
Zotero 插件